PROGNOSTIC VALUE OF ADMISSION-TO-DISCHARGE CHANGE IN INTEGRAL CONGESTION ASSESSMENT FOR PREDICTING ADVERSE OUTCOMES IN PATIENTS WITH DECOMPENSATED HEART FAILURE Article Kobalava Z., Tolkacheva V., Cabello-Montoya F., Sarlykov B., Galochkin S., Lapshin A.A., Diane M.L. Archives of Razi Institute. Razi Vaccine and Serum Research Institute. Vol. 77. 2022. P. 1049-1058
MULTIPARAMETRIC APPROACH TO CONGESTION ASSESSMENT FOR PREDICTING ALL-CAUSE MORTALITY IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS Article Sarlykov B., Tolkacheva V., Montoya F.C., Galochkin S., Diane M.L., Kobalava Z.H. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 23. 2021. P. 183-183
EVALUATION OF THE EFFECTIVENESS OF SINGLE-PILL COMBINATION WITH INDAPAMIDE AND AMLODIPINE IN PATIENTS OLDER 55 YEARS IN REAL-WORLD PRACTICE IN RUSSIA (ARBALET STUDY) Article Kobalava Z., Shavarova E., Tolkacheva V., Burtsev Y. Journal of Hypertension. Vol. 37. 2019.
AMBULATORY PARAMETERS OF BLOOD PRESSURE IN PATIENTS WITH DIFFERENT ETIOLOGY OF END-STAGE RENAL DISEASE Article Kobalava Z., Trukhanova M., Villevalde S., Tolkacheva V., Tolkacheva V. Journal of Hypertension. Vol. 36. 2018.
THE EFFECTS OF DURATION OF HEMODIALYSIS ON THE PARAMETERS OF HEMODYNAMICS IN PATIENTS WITH END-STAGE RENAL DISEASE Article Trukhanova M., Tolkacheva V., Villevalde S., Kobalava Z. Journal of Hypertension. Vol. 36. 2018.
PHARMACOKINETICS OF THE NEW HEPATITIS C VIRUS NS3 PROTEASE INHIBITOR NARLAPREVIR FOLLOWING SINGLE-DOSE USE WITH OR WITHOUT RITONAVIR IN PATIENTS WITH LIVER CIRRHOSIS Article Isakov V., Koloda D., Tikhonova N., Krasavina E., Samsonov M., Kikalishvili T., Lekishvili K., Malaya I., Ryska M., Tolkacheva V. Antimicrobial Agents and Chemotherapy. Vol. 60. 2016.
PHARMACOKINETIC PARAMETERS OF FIMASARTAN IN RUSSIAN PATIENTS WITH PRIMARY ARTERIAL HYPERTENSION Article Kobalava Z., Kotovskaya Y., Tolkacheva V. Journal of Hypertension. Vol. 34. 2016.
PHARMACOKINETIC PARAMETERS OF FIMASARTAN IN RUSSIAN PATIENTS WITH ARTERIAL HYPERTENSION Article Kobalava Z., Korneva E., Tolkacheva V., Kotovskaya Y., Samsonov M., Ajmi H., Dufour G. Journal of Hypertension. Vol. 33. 2015.
CYSTATIN C IS ASSOCIATED WITH HIGHER INTENSITY OF INFLAMMATION IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS Article Tyukhmenev E., Villevalde S., Akhmetov R., Tolkacheva V., Kobalava Z. Journal of Hypertension. Vol. 28. 2010.
OUICKI INDEX AND INFLAMMATION MARKERS IN PATIENTS WITH ARTERIAL HYPERTENSION AND UNTREATED DIABETES MELLITUS TYPE 2 Article Tolkacheva V., Villevalde S., Tyukhmenev E., Kobalava Z. Journal of Hypertension. Vol. 28. 2010.
GLOMERULAR FILTRATION RATE FORMULA FOR CLASSIFICATION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION AND GLUCOSE INTOLERANCE Article Tolkacheva V., Villevalde S., Tyukhmenev E., Kobalava Z. Journal of Hypertension. Vol. 28. 2010.
GLUCOSE LEVEL ON ADMISSION AND ACUTE HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION Article Tolkacheva V., Babaeva L., Pavlikova E., Moiseev V. Journal of Hypertension. Vol. 25. 2007.